Pharma Pulse 7/31/24: Forgetting the Patient, Five Fast Facts About IVIG & more
The latest news for pharma industry insiders.
You Are Forgetting the Patient, but You’re Not Alone
Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.
By functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.
Big Pharma Rallies and Moves Past Obesity
Rotation into laggard pharmaceutical stocks is being helped by optimism over regulations.
Advanced Clinical Announces Opening of New Office in India
Advanced Clinical announced the opening of a new office in Ahmedabad, India. This strategic expansion marks a significant milestone in its ongoing global expansion efforts and underscores a commitment to addressing the evolving needs of the company’s clients while becoming more competitive in the global market.
Miranda Schmalfuhs on LinkedIn
Check out the first part of my insightful talk with Charlotte Owens, MD, FACOG of Organon and keep your eyes on Pharmaceutical Executive for the other parts of our talk posting every morning this week!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
